0001179110-20-006750.txt : 20200601 0001179110-20-006750.hdr.sgml : 20200601 20200601161513 ACCESSION NUMBER: 0001179110-20-006750 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200528 FILED AS OF DATE: 20200601 DATE AS OF CHANGE: 20200601 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Smith Mark Douglas CENTRAL INDEX KEY: 0001756253 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37477 FILM NUMBER: 20933563 MAIL ADDRESS: STREET 1: C/O TELADOC HEALTH, INC. STREET 2: 2 MANHATTANVILLE ROAD, SUITE 203 CITY: PURCHASE STATE: NY ZIP: 10577 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Teladoc Health, Inc. CENTRAL INDEX KEY: 0001477449 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-OFFICES & CLINICS OF DOCTORS OF MEDICINE [8011] IRS NUMBER: 043705970 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2 MANHATTANVILLE ROAD STREET 2: SUITE 203 CITY: PURCHASE STATE: NY ZIP: 10577 BUSINESS PHONE: 2036352002 MAIL ADDRESS: STREET 1: 2 MANHATTANVILLE ROAD STREET 2: SUITE 203 CITY: PURCHASE STATE: NY ZIP: 10577 FORMER COMPANY: FORMER CONFORMED NAME: Teladoc, Inc. DATE OF NAME CHANGE: 20091123 4 1 edgar.xml FORM 4 - X0306 4 2020-05-28 0 0001477449 Teladoc Health, Inc. TDOC 0001756253 Smith Mark Douglas C/O TELADOC HEALTH, INC., 2 MANHATTANVILLE ROAD, SUITE 203 PURCHASE NY 10577 1 0 0 0 Restricted Stock Units 2020-05-28 4 M 0 3012 A 3012 D Restricted Stock Units 2020-05-28 4 M 0 3012 0.00 D Common Stock 3012 0 D Restricted Stock Units 2020-05-28 4 A 0 1049 0.00 A Common Stock 1049 1049 D Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. Each restricted stock unit represents a contingent right to receive one share of TDOC common stock. On May 30, 2019, the reporting person was granted 3,012 restricted stock units, vesting in full on May 28, 2020. The restricted stock units vest in full on the earlier of (i) May 28, 2021 and (ii) the day immediately preceding the issuer's 2021 annual meeting of stockholders. 50% of the vested shares will be delivered to the reporting person on the earliest to occur of (i) within 90 days following the date that is 30 days following the reporting person's separation of service, (ii) immediately prior to, on or within 30 days following a Change of Control (as defined in the issuer's Deferred Compensation Plan for Non-Employee Directors) and (iii) the reporting person's death. /s/ Adam C. Vandervoort, attorney-in-fact 2020-06-01